Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01428011 · ClinicalTrials.gov registry record
Patient-Provider Communication and Medication Adherence
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 114
- Enrollment target
NCT01428011 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 114 participants.
The verdict
NCT01428011 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how communication between African American and white patients with high blood pressure and his/her primary care provider effects whether a patient decides to take their high blood pressure medications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2014-03-01 |
| Est. Completion | 2015-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01428011
The ClinicalTrials.gov registry entry for NCT01428011 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01428011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01428011 about?
NCT01428011 is a clinical study titled "Patient-Provider Communication and Medication Adherence". The purpose of this study is to understand how communication between African American and white patients with high blood pressure and his/her primary care provider effects whether a patient decides to take their high blood pressure medications.
What is the current status of trial NCT01428011?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2014-03-01. Estimated completion is 2015-04-22.
Who is sponsoring clinical trial NCT01428011?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.